| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |